Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 19, 2026

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research
08:06

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

Published on: May 21, 2008

8.7K

Editorial

Dimitri M Kullmann1

  • 1London, UK.

Brain : a Journal of Neurology
|September 11, 2019
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Last Updated: Jan 19, 2026

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research
08:06

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

Published on: May 21, 2008

8.7K

Related Concept Videos

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research08:06

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

8.7K
In the past many in vitro culture systems -- mainly monolayer cultures -- often suffered from the disadvantage that differentiated primary cells had a relatively short life-span and de-differentiated during culture. As a consequence, most of their organ-specific functions were lost rapidly. Thus, in order to reproduce better conditions for these cells in vitro, modifications and adaptations have been made to conventional monolayer...
8.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Next-generation chemogenetic inhibition using a brain-permeant non-prescription agent.

Signal transduction and targeted therapy·2026
Same author

UCL Queen Square Institute of Neurology: 75 years of innovation.

The Lancet. Neurology·2026
Same author

Clinical and Molecular Genetic Characterization of Landau Kleffner Syndrome: An Observational Cohort and Experimental Study.

Annals of neurology·2025
Same author

Deciphering temporal gene expression dynamics during epilepsy development using a rat model of focal neocortical epilepsy.

Epilepsia·2024
Same author

Early developmental alterations of CA1 pyramidal cells in Dravet syndrome.

Neurobiology of disease·2024
Same author

Structure-function and pharmacologic aspects of ion channels relevant to neurologic channelopathies.

Handbook of clinical neurology·2024
Same journal

Disrupted WWOX-MYC interplay impairs neurogenesis in human brain organoids.

Brain : a journal of neurology·2026
Same journal

SMPD4 deficiency disrupts indirect neurogenesis and neuronal migration in gyrencephalic cortex.

Brain : a journal of neurology·2026
Same journal

Retinal hyper-reflective foci link retinal and cortical pathology in paediatric multiple sclerosis.

Brain : a journal of neurology·2026
Same journal

Two scripts, two pathways: dorsal-ventral biases in post-stroke kana-kanji agraphia.

Brain : a journal of neurology·2026
Same journal

Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severity.

Brain : a journal of neurology·2026
Same journal

Time to reconsider risk for psychosis?

Brain : a journal of neurology·2026
See all related articles